Link #1:
The article, “Increased Maternal Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) associated with older age at diagnosis of Type 1 diabetes in offspring”, is written by N.J. Leech, J. O’Sullivan, P. Avery, C. Howey, K. Burling, S. Iyer, L. Pascoe, M. Walker and T. Cheetham. From the EBSCO host database, I came across an article from Diabetic Medicine, which is a medical journal. These studies were conducted to find out if the evolution of Type 1 diabetes is affected by inherited differences in insulin response. During their investigation, there was no connection present between the age at diagnosis of Type 1 diabetes in children and the BMI standard score. The conclusion to their research was “maternal insulin resistance is associated with later onset of Type 1 diabetes.”
The Diabetic Medicine medical journal addressed this study from a sympathetic point of view. Their general target audience consisted of doctors and physicians who deal with Type 1 diabetes and possess an interest in Type 1 diabetes research, individuals already diagnosed with the disease, and people who personally know a person who is diagnosed. This was due to their Type 1 diabetic affiliations. This study points toward the need for improved maternal nutrition in ways that reduce insulin resistance. This study has its flaws because no one can predict that their child will be diagnosed with Type 1 diabetes, but you can only be aware of the disease’s presence after the child is born. The only way that this study can apply in the lives of diabetes sufferers is if all young women followed better dietary choices.
T. Cheetham, et al. "Increased Maternal Homeostasis Model Assessment Of Insulin Resistance (HOMA-IR) Associated With Older Age At Diagnosis Of Type 1 Diabetes In Offspring N. J. Leech Et Al. Phenotype And Diagnosis Of Type 1 Diabetes." Diabetic Medicine 27.12 (2010): 1450-1453. Academic Search Premier. Web. 23 Mar. 2012. <http://web.ebscohost.com/ehost/pdfviewer/pdfviewer?sid=9de8ee84-6697-49c2-aca5-58db5f71d1fa%40sessionmgr4&vid=2&hid=12>.
Link #2:
The article “The Impact of the Diabetes Control and Complications Trial and Humalog Insulin on Glycohemoglobin Levels and Severe Hypoglycemia in Type 1 Diabetes” was written by Chase, Peter, Tai Lockspeiser, Ben Peery, Mark Sheperd, Todd MacKenzie, James Anderson, and Satish K. Garg. These authors are affiliated with the Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences, and Eli Lilly and Company. Since the insulin is not made in the human body, there are some hazards of low blood sugar that can lead, very rapidly, to immediate death if you use injected insulin. This study is comparing new insulin’s effect. The conclusions show better control with the same incidence of hypoglycemia.
Although I saw that this article might contains bias because of one of the author’s affiliations with Eli Lilly and Company, which is a drug company that produces and sells insulin, I chose to use it while conducting my research to get a better rounded view of the subject. Because of the possible connection between this article and this company, I dug deeper to find any biases. After review, I could not find any biases expressed. This source is useful in adding to the body of knowledge that helps us study human response to outsourced insulin.
Chase, Peter, Tai Lockspeiser, Ben Peery, Mark Sheperd, Todd MacKenzie, James Anderson, and Satish K. Garg. "Diabetes Care." The Impact of the Diabetes Control and Complications Trial and Humalog Insulin on Glycohemoglobin Levels and Severe Hypoglycemia in Type 1 Diabetes. 2012. Web. 23 Mar. 2012. <http://care.diabetesjournals.org/content/24/3/430.short>.
Link #3:
This article, “Continuous Subcutaneous Insulin Infusion In Toddlers Starting At Diagnosis Of Type 1 Diabetes Mellitus. A Multicenter Analysis Of 104 Patients From 63 Centres In Germany And Austria”, was written by Berghaeuser, MA Kapellen, T. Heidtmann, B. Haberland, H. Klinkert, C. Holl and RW. This article is from the periodical Pediatric Diabetes. The study shows that it is safer and more effective to use a continuous insulin dose instead of individual shots. This maintains a healthy blood sugar level in young children when adjusted for activity. The parents of these children have to watch their children very carefully for signs of low blood sugar.
The authors’ purpose of this article is to provide educational information to promote a better understanding of Type 1 diabetes. This study from the Pediatric Diabetes medical journal shows an innovation in the delivery of insulin to the bloodstream of diabetic children. This article pertains to my topic because it details the system that is the next best action to a pancreatic transplant. This article I found has helped me provide background information so that they can have an appreciation of the complications of managing this disease.
Berghaeuser, MA Kapellen, T. Heidtmann, B. Haberland, H. Klinkert, C. Holl, RW. "Continuous Subcutaneous Insulin Infusion In Toddlers Starting At Diagnosis Of Type 1 Diabetes Mellitus. A Multicenter Analysis Of 104 Patients From 63 Centres In Germany And Austria." Pediatric Diabetes 9.6 (2008): 590-595. Advanced Placement Source. Web. 25 Mar. 2012. < http://web.ebscohost.com/ehost/pdfviewer/pdfviewer?sid=9d9c2a82-93d9-4c41-9a65-013cf62b8f60%40sessionmgr10&vid=2&hid=12>.